A Pre-Conference Program; additional registration was required
The understanding of cancer immunobiology has increased dramatically in recent years, leading to the successful development of novel immune-based treatment options to improve cancer patient outcomes. The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer. New this year, the Primer on Tumor Immunology and Cancer Immunotherapy™ also touched on emerging therapies and technologies to ensure attendees at all levels stay updated in our expanding field, while also laying a comprehensive foundational base for all SITC 2020 attendees.
Tuesday, Nov. 10, 2020*
9 a.m. - 3:55 p.m. EST
*Dates and times subject to change.
- Michael A. Curran, PhD – The University of Texas MD Anderson Cancer Center
- Yvonne Saenger, MD – Columbia University Irving Medical Center
SITC's Primer on Tumor Immunology and Cancer Immunotherapy™ is supported in part by grants from Bristol Myers Squibb and Pfizer, Inc.
*Program schedule subject to change.